Clinical Trials Directory

Trials / Completed

CompletedNCT03154580

Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users

Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users: A Pilot Test of Glutamatergic Modulation

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Wayne State University · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of the proposed study is to examine the relationship between marijuana reminders, or "cues", craving for marijuana, and marijuana use. The principal investigator is also assessing whether N-acetylcysteine, can reduce marijuana craving or use.

Detailed description

This study involves three screening sessions that could last about 3 hours each. Part of this study will be conducted on an inpatient unit where the participant will live for 4 straight nights. During the inpatient stay participants will participant in experimental sessions where they will be asked to smoke cigarettes containing either marijuana or placebo (a blank). Participants will be asked to take capsules that could contain N-acetylcysteine or placebo (blank). Participants will be asked to complete questionnaires and have vital signs (blood pressure, heart rate) monitored. Participants will be asked to participate in overnight sleep recordings, a polysomnogram (PSG).

Conditions

Interventions

TypeNameDescription
DRUGN-acetyl cysteineParticipants will receive 4 capsules at 11:15am on each experimental session day.

Timeline

Start date
2017-05-01
Primary completion
2023-06-27
Completion
2023-06-27
First posted
2017-05-16
Last updated
2024-04-23

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03154580. Inclusion in this directory is not an endorsement.